Association of Marketing and Communication Professionals Recognizes Drugwatch in Awards Spotlight
Editors carefully fact-check all Drugwatch.com content for accuracy and quality.
Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines.
We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.
The Association of Marketing and Communication Professionals has honored Drugwatch for its consequential reporting on the vaping industry’s marketing practices.
Judges of the 2020 MarCom Awards chose to feature Drugwatch’s investigative article “How Juul Created a Teen Vaping Epidemic” on the AMCP blog for a 2020 MarCom Awards Spotlight.
“We were incredibly impressed with your [article] and are excited to showcase your success,” MarCom Awards marketing director Bree Binder told Drugwatch in an email.
A group of communication professionals founded AMCP in 1994 as a way to recognize outstanding achievement and service to the communication profession with independent, fair and respected competition on an international level.
AMCP administers and judges several international competitions for communication professionals, including the MarCom Awards, which receives about 6,000 entries per year. According to the AMCP website, “the mission of the MarCom Awards is to honor excellence and recognize the creativity, hard work, and generosity of marketing and communication professionals.”
Through skilled research and original reporting, Drugwatch’s article employs Juul Labs’ internal documents and statements by its founders to reveal the company’s carefully planned effort to expose America’s youth to one of the world’s most addictive substances.
“The article is well researched, well written, and very alarming,” AMCP wrote on its blog.
Read the full 2020 MarCom Awards Spotlight by visiting the AMCP blog. For media inquiries and collaborations, contact Drugwatch Senior Writer Terry Turner at tturner@drugwatch.com.